Navigation Links
URAC Calls for Public Comment on Revisions to its Pharmacy Benefit Management (PBM) and Drug Therapy Management (DTM), Version 2.0 Standards and NEW Performance Measures, and PHARM Core, Version 3.0 Standards
Date:2/12/2009

Standards revision will allow for the inclusion of first-ever URAC pharmacy performance measures

WASHINGTON, Feb. 12 /PRNewswire-USNewswire/ -- Today URAC called for public comment on revisions to its Pharmacy Benefit Management (PBM) Version 2.0, Drug Therapy Management (DTM) Version 2.0, and PHARM Core Version 3.0 Standards. These revisions include proposed data collection measures on pharmacy performance, seen as a next critical step in the evolution of pharmacy benefit management.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030501/URACLOGO)

URAC, one of the nation's leading independent accrediting organizations, is seeking input from any interested parties, including consumers, purchasers, regulators, and industry organizations. Public comments are due no later than March 27, 2009.

PBM and DTM Accreditation Standards, first introduced in July of 2007, were created in an effort to promote industry best practices, encourage quality improvement, and protect and empower consumers. These initial products addressed the need for comprehensive assurance for consumers and purchasers that quality standards are met for consumer protection and empowerment, appropriate access to drugs and pharmacies, patient safety, and disclosure of pricing and contracting terms. PBM and DTM were the first two accreditation products introduced as part of URAC's Pharmacy Quality Management(R) Suite. Since then URAC has added three additional products to its PQM(R) Suite. All accreditation products within the suite were developed by URAC's Pharmacy Accreditation Advisory Group which includes a wide range of stakeholders: employers, consumers, pharmacy consultants, health plans, retail pharmacy, pharmacy benefits management organizations, pharmacy professional organizations, labor, and large public purchasing groups.


'/>"/>
SOURCE URAC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Broad-based group of physicians calls for improvement in stroke treatment
2. Virginia Tech Review Panel Calls For Reform of Mental Health Treatment Law
3. HIDA Calls for Scrutiny of Group Purchasing Organization Distributor Fee Structure
4. Fairbank Farms Voluntarily Recalls 85% Ground Round Beef Patties Sold Fresh from Shaws Due to Possible Health Risk
5. Nuvelo Announces Upcoming Conference Calls, Webcasts and Conference Participation
6. AOA President Calls on Congress to Reauthorize SCHIP and Take Action to Ensure Health Care Coverage for All Americans
7. Center for Health Transformation Founder Newt Gingrich Calls on Congress to Pass a Clean SCHIP Six-Month Extension
8. Catholic Charities USA Calls on Congress and the President to Protect the Health of Children; Urges President Not to Veto Vitally Important Bill
9. Health IT Now! Coalition Calls on Congress to Pass Health Information Technology Legislation This Year
10. AARP Calls on Governor Schwarzenegger to Discourage Veto of SCHIP Expansion Bill
11. AARP Maryland Calls on President Bush Not to Veto SCHIP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2014)... BUFFALO, N.Y. A novel compound that targets an ... host of cocaine addiction behaviors, including relapse behavior, a ... research provides strong evidence that this may be a ... no effective medications exist., The UB research was published ... last week. , In the study, the compound, RO5263397, ...
(Date:4/23/2014)... that can rapidly screen a large cell population ... that population has been seriously lacking," said Virginia ... Royal Society of Chemistry journal Chemical Science ... coworkers have developed a novel technique that detects ... Sci. , 2014, DOI: 10.1039/C4SC00578C, http://pubs.rsc.org/en/content/articlelanding/2014/sc/c4sc00578c#!divAbstract ). ...
(Date:4/23/2014)... as the United States, it may come as a surprise ... adequate food due to lack of money or other financial ... the University of Illinois using data from the National Health ... are dealing with hunger are also facing negative health and ... over age 60 faced the threat of hungerthat translates to ...
(Date:4/23/2014)... Occupational and Leisure Time Physical Activity on Mobility Limitation ... midlife increases the risk of mobility limitation in old ... is found in a study which followed up 5,200 ... conducted at the Gerontology Research Center in Finland and ... labor is often repetitive, wears the body and lasts ...
(Date:4/23/2014)... disease has been a rapidly evolving pursuit with ... crook in the research road, scientists have found ... associated with the disease. The report, which appears ... could have important implications for developing novel treatments. ... explain that for years, research has suggested a ...
Breaking Medicine News(10 mins):Health News:Novel compound halts cocaine addiction and relapse behaviors 2Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:More Americans in their golden years are going hungry 2Health News:Midlife occupational and leisure-time physical activity limits mobility in old age 2
... advanced colorectal cancer as intravenous treatment with a similar ... as those on standard chemotherapy, but the pill caused ... 5-fluorouracil (5-FU), the chemotherapy regimen most commonly used to ... to use and produces fewer side effects, and that's ...
... An experimental estrogen lotion appears to reduce the number of ... from a pivotal-stage trial of the drug Estrasorb. If approved ... therapy in lotion form.// ,The drug's developer Novavax ... lotion reduced by 80% the total number of hot flashes ...
... researchers are warning that blood transfusions can cause a ... to more than 50 deaths// nationwide since 1990. About ... patients receive transfusions each year. Testing for the antibodies ... routine screening of the nation's blood supply. ,The ...
... Women who gain 38 pounds or more while pregnant ... by 40%.,Excess pregnancy weight gain// doesn't increase breast cancer ... for post-menopausal women. ,The study found that ... raise their post-menopausal risk of developing breast cancer by ...
... Food and Drug Administration has approved a new treatment ... radiofrequency energy to// shrink small areas of the cornea, ... Unlike laser in situ keratomileusis (LASIK), in which the ... conductive keratoplasty does not require cutting or tissue removal. ...
... Drug Administration recommends pregnant women to avoid swordfish, shark, ... oysters, marlin, halibut, pike, walleye, white croaker, and largemouth ... and young children to eat only small amounts of ... Food and Drug Administration softened its warning to pregnant ...
Cached Medicine News:
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that a ... its catalogue: Global ... Systems -- Focus on End Users ... OBJECTIVES A drug delivery system ...
(Date:1/14/2014)... , Jan. 14, 2014 HeartWare International, Inc ... of less invasive, miniaturized circulatory support technologies that are ... that it expects revenues for the fourth quarter of ... 2013 revenues to approximately $208 million. "Our ...
(Date:1/14/2014)... HARRISBURG, Pa. , Jan. 14, 2014 Dynamic Healthcare ... ("GMH"), announced today that it acquired Progressive Home Medical Equipment, ... January 7, 2014. The terms of the acquisition were not ... medical equipment ("DME") company providing a wide range of sleep, ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3
... April 13, 2011 Cephalon, Inc. (Nasdaq: ... CXS Holdings Pty Ltd (Cephalon), has lodged the offer ... for ChemGenex Pharmaceuticals Limited (ASX: CXS) (ChemGenex) with the ... offering a 58 percent premium to the one-month volume ...
... Pharmaceuticals, Inc., the leader in the development of neurosteroids ... of a $3 million grant by the U.S. Department ... the treatment of Fragile-X Syndrome (FXS). Ganaxolone modulates GABA-A ... Early research suggests that normalizing neurosteroid levels with ganaxolone ...
Cached Medicine Technology:Cephalon Lodges Bidder's Statement for A$167 Million Offer for ChemGenex Pharmaceuticals 2Cephalon Lodges Bidder's Statement for A$167 Million Offer for ChemGenex Pharmaceuticals 3Marinus Pharmaceuticals Announces U.S. Department of Defense Grant to Study Ganaxolone in Fragile-X Syndrome 2
Tube for Right Bronchus - Ruschelit™ PVC. Color coded for easy identification of ports, balloons and 15mm connectors. High volume/low pressure cuffs. With Carina hook. X-ray opaque line. Gradua...
Laser resistant tubes for use with CO2 and KTP Lasers., ,Designed for airway management during laser surgery of the larynx or other areas in close proximity to the trachea....
Laryngectomy Tubes with special J-shape for convenient placement through a tracheostomy stoma....
SPIRAL-FLEX® Reinforced Oral/Nasal Cuffed Endotracheal Tubes...
Medicine Products: